Insider Trading activities of Boston Scientific Corp insiders. , Part 5

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Boston Scientific Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Boston Scientific Corp since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Boston Scientific Corp since 2005. The reporting company's ticker symbol is BSX. The reporting company's CIK number is 885725.
The total value of stock buying since 2005 is $23,762,101.
The total value of stock sales since 2005 is $869,016,554.
The total value of stock option exercises since 2005 is $78,809,293.



Table 2. Detailed insider stock purchases, sales, and option exercises of Boston Scientific Corp insiders (BSX) , Part 5
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-02-24 Dawkins Keith D (Sr. VP, Global Chief Med. Off.) Option Ex 2,410 .00 0
2012-02-24 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 1,760 3.12 5,500
2012-02-24 Phalen Michael P. (EVP & President, MedSurg) Option Ex 4,699 .00 0
2012-02-24 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 3,012 .00 0
2012-02-24 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 3,012 .00 0
2012-02-24 Kucheman William (Chief Executive Officer) Option Ex 3,012 .00 0
2012-02-24 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 3,012 .00 0
2012-02-24 Burns Brian R (EVP - Global Quality & Reg Aff) Option Ex 3,615 .00 0
2012-02-24 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 3,012 .00 0
2012-02-23 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 8,064 .00 0
2012-02-23 Mario Ernest (Director) Buy 10,000 5.91 59,100
2012-02-22 Mario Ernest (Director) Buy 10,000 5.93 59,300
2012-02-21 Mario Ernest (Director) Buy 20,000 6.12 122,400
2012-02-16 Neumann Lawrence R (SVP and Pres, Emerging Markets) Option Ex 4,943 .00 0
2012-02-16 Pierce David A (SVP and President, Endoscopy) Option Ex 5,121 .00 0
2012-02-16 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 2,115 .00 0
2012-02-16 Dawkins Keith D (Sr. VP, Global Chief Med. Off.) Option Ex 3,373 .00 0
2012-02-16 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 4,723 .00 0
2012-02-16 Pedersen John B. (Pres, Uro & Women's Health) Option Ex 4,048 .00 0
2012-02-16 Phalen Michael P. (EVP & President, MedSurg) Option Ex 4,723 .00 0
2012-02-16 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 4,588 .00 0
2012-02-16 Onuscheck John Michael (SVP & President, EMEA) Option Ex 5,060 .00 0
2012-02-16 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 28,434 .00 0
2012-02-16 Kucheman William (Chief Executive Officer) Option Ex 13,495 .00 0
2012-02-16 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 6,747 .00 0
2012-02-16 Burns Brian R (EVP - Global Quality & Reg Aff) Option Ex 6,747 .00 0
2012-02-16 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 20,242 .00 0
2012-02-13 Pierce David A (SVP and President, Endoscopy) Option Ex 1,605 .00 0
2012-02-13 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 1,638 .00 0
2012-02-13 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 2,923 .00 0
2012-02-13 Onuscheck John Michael (SVP & President, EMEA) Option Ex 1,638 .00 0
2012-02-12 Neumann Lawrence R (SVP and Pres, Emerging Markets) Option Ex 2,955 .00 0
2012-02-12 Pierce David A (SVP and President, Endoscopy) Option Ex 3,210 .00 0
2012-02-12 Nanavaty Maulik (SVP & Pres, Neuromodulation) Option Ex 5,391 .00 0
2012-02-12 Fitzgerald Joseph Michael (SVP & President, CRM) Option Ex 1,996 .00 0
2012-02-12 Pedersen John B. (Pres, Uro & Women's Health) Option Ex 998 .00 0
2012-02-12 Phalen Michael P. (EVP & President, MedSurg) Option Ex 3,274 .00 0
2012-02-12 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 3,194 .00 0
2012-02-12 Onuscheck John Michael (SVP & President, EMEA) Option Ex 3,993 .00 0
2012-02-12 Kucheman William (Chief Executive Officer) Option Ex 3,993 .00 0
2012-02-12 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 4,792 .00 0
2012-02-12 Burns Brian R (EVP - Global Quality & Reg Aff) Option Ex 3,993 .00 0
2012-01-07 Dawkins Keith D (Sr. VP, Chief Medical Officer) Option Ex 10,771 .00 0
2011-12-31 Elliott John Raymond Option Ex 333,333 .00 0
2011-11-29 Nicholas Nj Jr (Director) Buy 10,000 5.56 55,599
2011-11-28 Bartlett Katharine T (Director) Buy 8,000 5.42 43,360
2011-11-28 Mario Ernest (Director) Buy 100,000 5.40 540,000
2011-11-21 Mario Ernest (Director) Buy 25,000 5.30 132,500
2011-11-14 Connors Nelda J (Director) Sale 2,500 5.84 14,600
2011-11-04 Pierce David A (SVP and President, Endoscopy) Sale 15,869 5.77 91,548
2011-10-31 Kucheman William (Chief Executive Officer) Option Ex 6,500 .00 0
2011-10-31 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 6,500 .00 0
2011-10-30 Nanavaty Maulik (SVP & President, Neuromodula) Option Ex 4,580 .00 0
2011-10-30 Onuscheck John Michael (SVP & President, EMEA) Option Ex 2,290 .00 0
2011-10-26 Mario Ernest (Director) Buy 25,000 5.45 136,250
2011-10-25 Mario Ernest (Director) Buy 25,000 5.50 137,500
2011-09-07 Spriggs Otha T. Iii (SVP, Human Resources) Option Ex 7,198 .00 0
2011-08-11 Pedersen John B. (Pres, Uro & Women's Health) Sale 2,061 5.97 12,304
2011-08-03 Mario Ernest (Director) Buy 100 6.70 669
2011-08-02 Mario Ernest (Director) Buy 100,000 6.82 682,200
2011-07-01 Pedersen John B. (Pres, Uro & Women's Health) Option Ex 3,020 .00 0
2011-07-01 Phalen Michael P. (EVP & President, International) Option Ex 2,630 .00 0
2011-07-01 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 1,400 .00 0
2011-07-01 Kucheman William (EVP & Group Pres, CRV) Option Ex 4,300 .00 0
2011-07-01 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 8,000 .00 0
2011-07-01 Burns Brian R (EVP - Global Quality & Reg Aff) Option Ex 8,000 .00 0
2011-07-01 Moreci Stephen F (SVP, Global Sales Operations) Option Ex 8,000 .00 0
2011-06-20 Phalen Michael P. (EVP & President, International) Option Ex 1,900 .00 0
2011-06-20 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 1,013 .00 0
2011-06-16 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 14,662 .00 0
2011-06-06 Leno Sam R (EVP & Chief Operations Officer) Option Ex 100,000 .00 0
2011-05-23 Nicholas Nj Jr (Director) Buy 10,000 6.57 65,700
2011-05-17 Mario Ernest (Director) Buy 272 6.72 1,827
2011-05-13 Nicholas Nj Jr (Director) Buy 20,000 6.78 135,500
2011-05-13 Mario Ernest (Director) Buy 2,228 6.72 14,972
2011-05-09 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 2,350 .00 0
2011-05-02 Pedersen John B. (Pres, Uro & Women's Health) Sale 4,081 7.64 31,182
2011-05-02 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 14,750 .00 0
2011-02-28 Fitzgerald Joseph Michael (SVP & President, Endovascular) Option Ex 3,375 .00 0
2011-02-24 Dawkins Keith D (Sr. VP, Chief Medical Officer) Option Ex 2,410 .00 0
2011-02-24 Fitzgerald Joseph Michael (SVP & President, Endovascular) Option Ex 1,326 .00 0
2011-02-24 Pedersen John B. (Pres, Uro & Women's Health) Option Ex 1,326 .00 0
2011-02-24 Phalen Michael P. (EVP & President, International) Option Ex 4,699 .00 0
2011-02-24 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 3,012 .00 0
2011-02-24 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 3,012 .00 0
2011-02-24 Kucheman William (EVP & Group Pres, CRV) Option Ex 3,012 .00 0
2011-02-24 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 3,012 .00 0
2011-02-24 Burns Brian R (EVP - Global Quality & Reg Aff) Option Ex 3,615 .00 0
2011-02-24 Leno Sam R (EVP & Chief Operations Officer) Option Ex 6,024 .00 0
2011-02-24 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 3,012 .00 0
2011-02-23 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 8,065 .00 0
2011-02-16 Dawkins Keith D (Sr. VP, Chief Medical Officer) Option Ex 3,374 .00 0
2011-02-16 Fitzgerald Joseph Michael (SVP & President, Endovascular) Option Ex 4,724 .00 0
2011-02-16 Pedersen John B. (Pres, Uro & Women's Health) Option Ex 4,049 .00 0
2011-02-16 Phalen Michael P. (EVP & President, International) Option Ex 4,724 .00 0
2011-02-16 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 4,589 .00 0
2011-02-16 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 5,061 .00 0
2011-02-16 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 28,435 .00 0
2011-02-16 Kucheman William (EVP & Group Pres, CRV) Option Ex 13,496 .00 0
2011-02-16 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 6,748 .00 0
2011-02-16 Burns Brian R (EVP - Global Quality & Reg Aff) Option Ex 6,748 .00 0
2011-02-16 Leno Sam R (EVP & Chief Operations Officer) Option Ex 23,496 .00 0
2011-02-16 Capello Jeffrey D (EVP & Chief Financial Officer) Option Ex 20,244 .00 0
2011-02-16 Moreci Stephen F (SVP, Global Sales Operations) Option Ex 5,061 .00 0
2011-02-14 Fitzgerald Joseph Michael (SVP & President, Endovascular) Option Ex 4,916 .00 0
2011-02-14 Pedersen John B. (Pres, Uro & Women's Health) Option Ex 998 .00 0
2011-02-14 Phalen Michael P. (EVP & President, International) Option Ex 3,274 .00 0
2011-02-14 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 3,194 .00 0
2011-02-14 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 5,628 .00 0
2011-02-14 Kucheman William (EVP, & Group Pres, CRV) Option Ex 3,993 .00 0
2011-02-14 Pucel Kenneth (EVP, Global Ops & Technology) Option Ex 4,792 .00 0
2011-02-14 Burns Brian R (EVP - Global Quality & Reg Aff) Option Ex 3,993 .00 0
2011-02-14 Leno Sam R (EVP & Chief Operations Officer) Option Ex 10,982 .00 0
2011-02-14 Moreci Stephen F (SVP, Global Sales Operations) Option Ex 2,995 .00 0
2011-02-07 Mario Ernest (Director) Buy 50,000 6.94 347,000
2011-01-07 Dawkins Keith D (Sr. VP, Chief Medical Officer) Option Ex 10,771 .00 0
2011-01-03 Fitzgerald Joseph Michael (SVP & President, Endovascular) Option Ex 767 .00 0
2011-01-03 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 588 .00 0
2010-12-31 Elliott John Raymond (President and CEO) Option Ex 500,000 .00 0
2010-11-15 Lance Jean Fitterer (SVP & Chief Compliance Officer) Sale 2,963 6.74 19,970
2010-11-15 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 2,963 6.12 18,148
2010-11-12 Pedersen John B. (Pres, Uro & Women's Health) Sale 3,502 6.77 23,715
2010-11-04 Mario Ernest (Director) Buy 10,000 6.44 64,390
2010-11-03 Nicholas Peter M (Director) Sale 75,000 6.43 482,025
2010-11-02 Nicholas Peter M (Director) Sale 25,000 6.40 159,975
2010-11-01 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 2,290 .00 0
2010-11-01 Kucheman William (EVP, Cardiology) Option Ex 6,500 .00 0
2010-11-01 Pucel Kenneth (EVP, Global Operations) Option Ex 6,500 .00 0
2010-11-01 Nicholas Peter M (Director) Sale 25,000 6.36 159,075
2010-10-29 Nicholas Peter M (Director) Sale 25,000 6.34 158,550
2010-10-28 Nicholas Peter M (Director) Sale 25,000 6.35 158,700
2010-10-27 Nicholas Peter M (Director) Sale 25,000 6.28 156,975
2010-10-26 Nicholas Peter M (Director) Sale 25,000 6.29 157,350
2010-10-25 Nicholas Peter M (Director) Sale 25,000 6.33 158,150
2010-10-22 Nicholas Peter M (Director) Sale 25,000 6.32 158,050
2010-10-21 Nicholas Peter M (Director) Sale 25,000 6.36 158,900
2010-10-20 Nicholas Peter M (Director) Sale 25,000 6.47 161,800
2010-10-19 Nicholas Peter M (Director) Sale 25,000 6.07 151,800
2010-10-18 Nicholas Peter M (Director) Sale 25,000 6.16 154,000
2010-10-15 Lance Jean Fitterer (SVP & Chief Compliance Officer) Sale 2,963 6.26 18,548
2010-10-15 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 2,963 6.12 18,148
2010-10-15 Nicholas Peter M (Director) Sale 25,000 6.18 154,400
2010-10-14 Nicholas Peter M (Director) Sale 25,000 6.15 153,825
2010-10-13 Nicholas Peter M (Director) Sale 25,000 6.21 155,375
2010-10-12 Nicholas Peter M (Director) Sale 25,000 6.12 153,100
2010-10-11 Nicholas Peter M (Director) Sale 25,000 6.12 153,125
2010-10-08 Nicholas Peter M (Director) Sale 25,000 6.16 153,950
2010-10-07 Nicholas Peter M (Director) Sale 25,000 6.13 153,175
2010-10-06 Nicholas Peter M (Director) Sale 25,000 6.12 153,050
2010-10-05 Nicholas Peter M (Director) Sale 25,000 6.14 153,475

Insider trading activities including stock purchases, stock sales, and option exercises of BSX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Boston Scientific Corp (symbol BSX, CIK number 885725) see the Securities and Exchange Commission (SEC) website.